Petragen, Inc.
Precision therapeutics targeting pathological mineralization diseases
- Sector
- Biotech
- Headquarters
- Davie, FL
- Founded
- 2020
- Latest Form D
- $495K, Jun 2026
- Total capital
- $1.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.1M
- 2 Form D · last Jun 2026
- 4 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 13 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$495K
- Private capital raisedForm D · SEC · 1st filing$651K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- David KolbExecutive Officer, DirectorNamed in SEC Form D filings
- Demetrios Braddock, MD, PhDPromoterNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 13- PendingInhibitors Of ENPP1 And Modulation Of Bone GrowthUSPTOApplication 18308288
- PendingCompositions Of ENPP1 Inhibitors And Uses ThereofUSPTOApplication 18298059
- PendingEnhanced Inhibitors Of ENPP1 And Uses ThereofUSPTOApplication 19162587
Show all 13 patent records
- Inhibitors Of ENPP1 And Modulation Of Bone GrowthNov 2, 2023 · Application 18308288Pending
- Compositions Of ENPP1 Inhibitors And Uses ThereofOct 12, 2023 · Application 18298059Pending
- Enhanced Inhibitors Of ENPP1 And Uses ThereofApplication 19162587Pending
- Formulations Comprising ENPP1 InhibitorsApplication 63693651Pending
- New Uses Of ENPP1 InhibitorsApplication 63693635Pending
- Enhanced Inhibitors Of ENPP1 And Uses ThereofApplication PCTUS2024019100Pending
- Enhanced Inhibitors Of ENPP1 And Uses ThereofApplication 63549101Pending
- Inhibitors Of ENPP1 And Modulation Of Bone GrowthApplication PCTUS2023020138Pending
- Enhanced Inhibitors Of ENPP1 And Uses ThereofApplication 63488994Pending
- Inhibitors Of ENPP1 And Modulation Of Bone GrowthApplication 63336630Pending
- Formulations Comprising ENPP1 InhibitorsApplication PCTUS2025045960Pending
- Compositions Of ENPP1 Inhibitors And Uses ThereofApplication 63328795Pending
- New Uses Of ENPP1 InhibitorsApplication PCTUS2025045959Pending
Related companies, and why
- MedGene Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- LevEllis LLCSimilar federal contract value in Biotech · null in contracts
- ICaPath, Inc.Similar federal contract value in Biotech · null in contracts
- BioPhoundry, Inc.Similar federal contract value in Biotech · null in contracts
- NeuroInitiative, LLCSimilar federal contract value in Biotech · null in contracts
- Versanis BioSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .